Comparative in vitro sensitivity of human cholangiocarcinoma and colon adenocarcinoma cells to anticancer agents

Raffaella Villa, Daniela Gornati, Nadia Zaffaroni, Silvia Veneroni, Paolo Bidoli, Aldo Severini

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We comparatively investigated the sensitivity of a human cholangiocarcinoma cell line (SG231) and an adenocarcinoma cell line (WiDr) to mitoxantrone (MX), taxol (TX), mitomycin C (MMC), doxorubicin (DX), cisplatin (CDDP) and 5-fluorouracil (5FU) by the sulforhodamine B assay. The lower susceptibility of SG231 to 5FU, to CDDP, to DX and to MMC than WiDr was observed, whereas the sensitivity of the two cell lines to MX and TX was similar. We also investigated the ability of a chemical modulator lonidamine (LND), and hyperthermia to enhance the cytotoxic activity of the different drugs in the SG231 cell line. No potentiation of MX or CDDP activity was observed after a 2 hours treatment in hyperthermic conditions (42°C). Conversely, a slight potentiation of a 2 hours pretreatment with MX and DX was obtained by a 24 hours post treatment with LND.

Original languageEnglish
Pages (from-to)961-968
Number of pages8
JournalAnticancer Research
Volume17
Issue number2 A
Publication statusPublished - 1997

Fingerprint

Cholangiocarcinoma
Mitoxantrone
Antineoplastic Agents
Doxorubicin
Mitomycin
Colon
Adenocarcinoma
Cisplatin
Cell Line
Paclitaxel
lissamine rhodamine B
Fluorouracil
Fever
In Vitro Techniques
Pharmaceutical Preparations

Keywords

  • Anticancer agents
  • Cytotoxicity
  • Human cholangiocarcinoma
  • Human colon adenocarcinoma
  • Modulators
  • Sulforhodamine assay

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Comparative in vitro sensitivity of human cholangiocarcinoma and colon adenocarcinoma cells to anticancer agents. / Villa, Raffaella; Gornati, Daniela; Zaffaroni, Nadia; Veneroni, Silvia; Bidoli, Paolo; Severini, Aldo.

In: Anticancer Research, Vol. 17, No. 2 A, 1997, p. 961-968.

Research output: Contribution to journalArticle

Villa, Raffaella ; Gornati, Daniela ; Zaffaroni, Nadia ; Veneroni, Silvia ; Bidoli, Paolo ; Severini, Aldo. / Comparative in vitro sensitivity of human cholangiocarcinoma and colon adenocarcinoma cells to anticancer agents. In: Anticancer Research. 1997 ; Vol. 17, No. 2 A. pp. 961-968.
@article{7c27a6ea3d5e454682b759250dcac854,
title = "Comparative in vitro sensitivity of human cholangiocarcinoma and colon adenocarcinoma cells to anticancer agents",
abstract = "We comparatively investigated the sensitivity of a human cholangiocarcinoma cell line (SG231) and an adenocarcinoma cell line (WiDr) to mitoxantrone (MX), taxol (TX), mitomycin C (MMC), doxorubicin (DX), cisplatin (CDDP) and 5-fluorouracil (5FU) by the sulforhodamine B assay. The lower susceptibility of SG231 to 5FU, to CDDP, to DX and to MMC than WiDr was observed, whereas the sensitivity of the two cell lines to MX and TX was similar. We also investigated the ability of a chemical modulator lonidamine (LND), and hyperthermia to enhance the cytotoxic activity of the different drugs in the SG231 cell line. No potentiation of MX or CDDP activity was observed after a 2 hours treatment in hyperthermic conditions (42°C). Conversely, a slight potentiation of a 2 hours pretreatment with MX and DX was obtained by a 24 hours post treatment with LND.",
keywords = "Anticancer agents, Cytotoxicity, Human cholangiocarcinoma, Human colon adenocarcinoma, Modulators, Sulforhodamine assay",
author = "Raffaella Villa and Daniela Gornati and Nadia Zaffaroni and Silvia Veneroni and Paolo Bidoli and Aldo Severini",
year = "1997",
language = "English",
volume = "17",
pages = "961--968",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "2 A",

}

TY - JOUR

T1 - Comparative in vitro sensitivity of human cholangiocarcinoma and colon adenocarcinoma cells to anticancer agents

AU - Villa, Raffaella

AU - Gornati, Daniela

AU - Zaffaroni, Nadia

AU - Veneroni, Silvia

AU - Bidoli, Paolo

AU - Severini, Aldo

PY - 1997

Y1 - 1997

N2 - We comparatively investigated the sensitivity of a human cholangiocarcinoma cell line (SG231) and an adenocarcinoma cell line (WiDr) to mitoxantrone (MX), taxol (TX), mitomycin C (MMC), doxorubicin (DX), cisplatin (CDDP) and 5-fluorouracil (5FU) by the sulforhodamine B assay. The lower susceptibility of SG231 to 5FU, to CDDP, to DX and to MMC than WiDr was observed, whereas the sensitivity of the two cell lines to MX and TX was similar. We also investigated the ability of a chemical modulator lonidamine (LND), and hyperthermia to enhance the cytotoxic activity of the different drugs in the SG231 cell line. No potentiation of MX or CDDP activity was observed after a 2 hours treatment in hyperthermic conditions (42°C). Conversely, a slight potentiation of a 2 hours pretreatment with MX and DX was obtained by a 24 hours post treatment with LND.

AB - We comparatively investigated the sensitivity of a human cholangiocarcinoma cell line (SG231) and an adenocarcinoma cell line (WiDr) to mitoxantrone (MX), taxol (TX), mitomycin C (MMC), doxorubicin (DX), cisplatin (CDDP) and 5-fluorouracil (5FU) by the sulforhodamine B assay. The lower susceptibility of SG231 to 5FU, to CDDP, to DX and to MMC than WiDr was observed, whereas the sensitivity of the two cell lines to MX and TX was similar. We also investigated the ability of a chemical modulator lonidamine (LND), and hyperthermia to enhance the cytotoxic activity of the different drugs in the SG231 cell line. No potentiation of MX or CDDP activity was observed after a 2 hours treatment in hyperthermic conditions (42°C). Conversely, a slight potentiation of a 2 hours pretreatment with MX and DX was obtained by a 24 hours post treatment with LND.

KW - Anticancer agents

KW - Cytotoxicity

KW - Human cholangiocarcinoma

KW - Human colon adenocarcinoma

KW - Modulators

KW - Sulforhodamine assay

UR - http://www.scopus.com/inward/record.url?scp=0030932752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030932752&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 961

EP - 968

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 2 A

ER -